Skip to main content

Result releasedAnnolyse analysis published

Ryman’s after-tax loss widened despite a narrower pre-tax loss

The restated comparison separates the tax charge, property fair-value movements, operating performance and resident cash flows.

RYM revenue trajectory

Revenue context before the current result.

Loading chart...
FY22 revenue trajectory was $508.8m.

RYM operating cash flow

Operating cash flow across covered periods.

Loading chart...
FY25 was $410.3m, versus $586m in FY22.

RYM working-capital movement

Operating working-capital absorption or release by reporting period.

Loading chart...
FY25 was -$2m, versus $155.7m in FY22.

RYM NPAT trajectory

Statutory profit after tax across covered periods.

Loading chart...
FY25 was -$436.8m, versus $692.9m in FY22.

Market context

Valuation

These ratios pair a market close from around the result date with verified filing data. An unavailable metric means the required inputs were missing or unsuitable for comparison.

Prices as at close, 20 November 2026

Price and market cap

The latest close and share count context for the market price.

Market cap

$1.9b

i

End-of-day close multiplied by current shares on issue.

Profitability multiples

How the market price compares with recent earnings and cash-flow inputs.

P/E

Not available

i

Not meaningful when recent earnings are negative.

EPS

-0.17

i

Recent filing-derived earnings per share.

PEG

Not available

i

Not available for this company right now.

EV/EBITDA

Not available

i

Not available for this company right now.

P/FCF

16.57x

i

Market cap compared with recent free cash flow.

P/B

0.46x

i

Market value compared with latest reported equity.

Income and investment-company measures

Yield and investment-company valuation where supported.

Dividend yield

0.0%

i

Trailing dividends compared with the latest close.

Total return

Not available

i

Available once dividend and adjustment data are verified.

Release date
29 May 2025
Published
23 October 2026

Key metrics

Numbers worth scanning first

FY25 vs FY24

Revenue

n/m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Net profit after tax

−$436.8m

Caveat: metric quality flags apply; use this value with basis context.

Net cash inflow from operating activities

$410.3m

Caveat: metric quality flags apply; use this value with basis context.

Full-year dividend per share

0.0c

Caveat: metric quality flags apply; use this value with basis context.

EBITDAF

$45.5m

Caveat: metric quality flags apply; use this value with basis context.

Profit before tax

−$215.4m

Caveat: metric quality flags apply; use this value with basis context.

Cash and cash equivalents

$17.7m

-57.8% ↓ vs $41.8m

Total assets

n/m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Analysis ofRYM FY25Result releasedAnnolyse analysis published

What changed

Ryman reported revenue of NZ$760.7m for the year ended 31 March 2025, compared with restated FY24 revenue of NZ$689.9m

The pre-tax loss narrowed to NZ$215.4m from NZ$281.9m, while the after-tax loss widened to NZ$436.8m from NZ$169.7m. These are comparisons against the current report's restated prior-year figures. The profit before tax margin improved by 12.6 percentage points, from -40.9% to -28.3%; that measure includes the property fair-value movements and impairment charges discussed below.

The tax line changed from a NZ$112.3m credit to a NZ$221.4m expense. The different direction of the pre-tax and after-tax loss comparisons therefore needs that explicit tax context, rather than a claim that the after-tax movement alone measures operating performance.

What matters

The source separately reports a positive NZ$169.2m fair-value movement in investment properties, compared with a NZ$39.1m negative movement in restated FY24

Impairment losses were NZ$172.9m, compared with NZ$96.5m. The company's separately defined profit before tax and fair-value movements remained a loss of NZ$384.6m, compared with a NZ$242.8m loss.

The company also reports non-GAAP operating EBITDAF of NZ$45.5m, compared with restated NZ$14.8m. That operating measure has a different definition from statutory pre-tax profit and net profit. The figures should retain their distinct labels and should not be treated as interchangeable measures of the result.

Expectations

The statutory loss, the non-GAAP operating measure and the fair-value movement describe different parts of FY25

None alone establishes the future level of operating earnings, property valuations or taxable profit.

No new numerical earnings, funding or distribution forecast is inferred from these actuals. An outlook assessment requires the relevant operational assumptions and the company's specifically stated guidance for the next period.

Quality of result

Operating cash inflow was NZ$410.3m, compared with restated NZ$595.3m

Ryman's cash flows include resident occupation-right receipts, repayments and refundable accommodation deposits. This operating cash total should therefore not be interpreted as ordinary industrial-company EBITDA cash conversion.

Closing cash was NZ$17.7m. The face value of loans and borrowings was NZ$1.7b, compared with NZ$2.6b on the same face-value basis. The cash-flow statement separately records net equity-raising proceeds of NZ$970.2m and loan repayments; the financing transactions are distinct from trading profit.

Net trade receivables were NZ$22.1m, compared with restated NZ$21.7m. The much larger trade-and-other-receivables balance includes occupancy advances, refundable accommodation deposits and prepayments, and should not be substituted for actual trade debtors. No dividends were declared or paid during FY25 or FY24.

Unresolved

Open questions

How will care and village operations develop separately from property fair values and impairment charges? How will resident cash receipts, repayments and the development programme affect future funding needs? What future taxable-profit assumptions support the tax position? These questions require their own source evidence; the current positive operating cash inflow and the non-GAAP operating measure do not by themselves settle them.

Ask about RYM FY25

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Ryman Healthcare's FY25 result.

What drove RYM's FY25 result?Why does "The source separately reports a positive NZ$169.2m fair-value movement in investment properties, compared with a NZ$39.1m negative movement in restated FY24" matter?How strong was the cash and earnings quality in FY25?What should I watch next for RYM after FY25?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

FY25 company presentation with restatedFY24 OperatingEBITDAF/NTA

FY25 / results presentation

FY25 consolidated statements

FY25 / financial report

Prior comparable period

FY24 restated comparative inFY25 consolidated statements

FY24 / financial report

FY25 company presentation with restatedFY24 OperatingEBITDAF/NTA

FY24 / results presentation

Get notified when RYM publishes next

Get the next Ryman Healthcare briefing and related NZX reporting-season updates by email.